Kötter I - Search Results

1

Behçet's disease in patients of German and Turkish origin--a comparative study.

Kötter I, Vonthein R, Günaydin I, Müller C, Kanz L, Zierhut M, Stübiger N. Kötter I, et al. Adv Exp Med Biol. 2003;528:53-8. doi: 10.1007/0-306-48382-3_9. Adv Exp Med Biol. 2003. PMID: 12918660 No abstract available.

2

The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action.

Kötter I, Günaydin I, Treusch M, Zierhut M, Kanz L, Stübiger N. Kötter I, et al. Adv Exp Med Biol. 2003;528:503-9. doi: 10.1007/0-306-48382-3_102. Adv Exp Med Biol. 2003. PMID: 12918753 Review. No abstract available.

3

Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

Kötter I, Zierhut M, Eckstein A, Vonthein R, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Kanz L, Stübiger N. Kötter I, et al. Adv Exp Med Biol. 2003;528:521-3. doi: 10.1007/0-306-48382-3_104. Adv Exp Med Biol. 2003. PMID: 12918755 Clinical Trial. No abstract available.

4

Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment.

Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N. Deuter CM, et al. Among authors: kotter i. Adv Exp Med Biol. 2003;528:525-8. doi: 10.1007/0-306-48382-3_105. Adv Exp Med Biol. 2003. PMID: 12918756 Clinical Trial. No abstract available.

5

Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a.

Stübiger N, Besch D, Deuter CM, Zierhut M, Kötter I. Stübiger N, et al. Among authors: kotter i. Adv Exp Med Biol. 2003;528:529-32. doi: 10.1007/0-306-48382-3_106. Adv Exp Med Biol. 2003. PMID: 12918757 Clinical Trial. No abstract available.

6

Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease.

Treusch M, Stübiger N, Vonthein R, Baur M, Koch S, Günaydin I, Kanz L, Zierhut M, Kötter I. Treusch M, et al. Among authors: kotter i. Adv Exp Med Biol. 2003;528:533-5. doi: 10.1007/0-306-48382-3_107. Adv Exp Med Biol. 2003. PMID: 12918758 Clinical Trial. No abstract available.

7

Interferon alpha 2a in IRPB-derived peptide-induced EAU--part I.

Stübiger N, Crane IJ, Kötter I, Lamont GR, Zoeller M, Günthert U, Forrester JV, Zierhut M, Stiemer RH. Stübiger N, et al. Among authors: kotter i. Adv Exp Med Biol. 2003;528:537-40. doi: 10.1007/0-306-48382-3_108. Adv Exp Med Biol. 2003. PMID: 12918759 No abstract available.

8

Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis.

Kötter I, Vonthein R, Müller CA, Günaydin I, Zierhut M, Stübiger N. Kötter I, et al. J Rheumatol. 2004 Jan;31(1):133-9. J Rheumatol. 2004. PMID: 14705232

9

Therapeutic implications for interferon-alpha in arthritis.

Kötter I, Stübiger N. Kötter I, et al. J Rheumatol. 2004 Mar;31(3):624-5; author reply 625. J Rheumatol. 2004. PMID: 14994421 No abstract available.

10

Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.

Kötter I, Vonthein R, Zierhut M, Eckstein AK, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Stübiger N. Kötter I, et al. Semin Arthritis Rheum. 2004 Apr;33(5):311-9. doi: 10.1016/j.semarthrit.2003.09.005. Semin Arthritis Rheum. 2004. PMID: 15079762 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters